Hummingbird Bioscience
Hummingbird Bioscience
Hummingbird Bioscience
  • About Us
  • Science
    • ADC Platform
    • Antibody Platform
    • Publications
  • Pipeline
    • HMBD-001
    • HMBD-501
  • News
  • Partnering
  • Patients
  • Contact
  • Join Us
    Category Archives

    News – 2025

  • All
  • News
  • Publications & Posters
    • News
    • News - 2025

    Hummingbird Bioscience Licenses HMBD-002, Phase II-Ready Anti-VISTA Monoclonal Antibody to Percheron Therapeutics

    Percheron Therapeutics obtains exclusive worldwide rights to Hummingbird Bioscience’s HMBD-002 for further clinical development. Hummingbird…

    Continue Reading
    • News
    • News - 2025

    Hummingbird Bioscience Appoints Dipti Thakkar, PhD, as Chief Operating Officer

    Hummingbird Bioscience today announced the internal appointment of Dipti Thakkar, PhD, as Chief Operating Officer.

    Continue Reading
    • News
    • News - 2025

    Callio Therapeutics Launches with US$187 Million Series A to Advance Multi-Payload Antibody-Drug Conjugate Platform Through Clinical Proof-of-Concept

    Callio Therapeutics, a biotechnology company focused on realizing the promise of multi-payload antibody-drug conjugates (ADCs)…

    Continue Reading
    • News
    • News - 2025

    Hummingbird Bioscience Licenses Novel Antibodies to Immunome

    Hummingbird Bioscience, a precision biotherapeutics company discovering and developing transformative biologics for hard-to-treat diseases, today…

    Continue Reading

Hummingbird Bioscience

The Galen
61 Science Park Road, #06-15
Singapore 117525


Hummingbird Bioscience Twitter Hummingbird Bioscience Twitter Hummingbird Bioscience LinkedinHummingbird Bioscience Linkedin Hummingbird Bioscience YouTube Hummingbird Bioscience YouTube
Subscribe to our updates
Registered Company No: 201505192N
PRIVACY POLICY | © 2025 Hummingbird Bioscience
  • About Us
  • Science
    • ADC Platform
    • Antibody Platform
    • Publications
  • Pipeline
    • HMBD-001
    • HMBD-501
  • News
  • Partnering
  • Patients
  • Contact
  • Join Us

What are you looking for?

Subscribe to our updates

    *indicates required

    You can unsubscribe at any time by clicking the link in the footer of our emails. For information about our privacy practices, please visit our website. For questions about this mailing list, please email communications@hummingbirdbio.com

    We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.

    Close